Related Experiment Video
Updated: Feb 3, 2026

Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
Published on: March 29, 2024
[Anesthetic Management of Children with Upper Respiratory Tract Infections]
Insights
Children with upper respiratory infections face increased risks during anesthesia. Careful evaluation is crucial, as no standard guidelines exist for proceeding with or postponing elective surgeries in these pediatric patients.
Area of Science:
- Anesthesiology
- Pediatric Medicine
- Respiratory Medicine
Background:
- Respiratory adverse events (cough, hypoxia, laryngospasm, bronchospasm, stridor) are significant causes of morbidity and mortality in pediatric anesthesia.
- Upper respiratory tract infection (URTI) is an independent risk factor for perioperative respiratory adverse events in children.
- Current decision-making for anesthesia in children with URTI lacks standardized guidelines, relying on institutional, patient, surgical, and social factors.
Purpose of the Study:
- To highlight the challenges in managing pediatric patients with URTI undergoing anesthesia.
- To emphasize the need for anesthesiologists to be familiar with preventing and treating perioperative respiratory adverse events.
- To underscore the critical evaluation required for children with URTI before elective surgery.
Main Methods:
- Review of existing literature on respiratory adverse events during pediatric anesthesia.
- Analysis of the risk factors associated with URTI in the perioperative period.
- Discussion of the complexities in decision-making regarding anesthesia for children with URTI.
Main Results:
- Children with URTI present a higher risk for perioperative respiratory adverse events.
- Laryngospasm and bronchospasm are particularly serious complications that can lead to severe outcomes, including death.
- Standardized guidelines for managing anesthesia in these children are currently lacking.
Conclusions:
- Anesthesiologists must be well-versed in the prevention and treatment of perioperative respiratory adverse events in pediatric patients.
- Careful, individualized assessment is essential for children with URTI undergoing elective surgery.
- Further research is needed to establish standardized guidelines for this patient population.
Abstract:
Respiratory adverse events, such as cough, hypoxia, laryngospasm, bronchospasm and stridor, are major causes of morbidity and mortality during pediatric anesthesia. Since several studies have shown that upper respiratory tract infection is an independent risk factor for perioperative respiratory adverse events, children presenting for elective surgery with upper respiratory tract infection require a careful evaluation to decide whether or not to proceed with anesthesia. However, there are no standard guidelines to proceed with or postpone anesthesia, and thus the decision pro- cess is often based on unique institutional, patient, surgical, and social factors. Most of perioperative respira- tory adverse events can be anticipated, recognized, and treated easily, while laryngospasm and bronchospasm that can lead to oxygen desaturation and death are serious complications and their prevention and treat- ment are challenging. Anesthesiologists should be fa- miliarized with the prevention and treatment of peri- operative respiratory adverse events.
Related Concept Videos
Anatomy of Respiratory System I: Upper Respiratory Tract
Nose and nasal cavity
The nose and nasal cavity represent the main external openings of the respiratory tract....
Anatomy of Respiratory System II: Lower Respiratory Tract
The Larynx
It is located between the pharynx and the trachea, acts as a passageway for air, and hosts several critical structures, such as the epiglottis, vocal cords, and glottis. The epiglottis acts as a gateway, guiding food to the...
Urinary Tract Infection IV: Nursing Management
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...

